يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"KREMER HOVINGA, Johanna"', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1

    المصدر: Stroke. 53(10):3206-3210

    وصف الملف: print

  2. 2
    دورية أكاديمية

    المساهمون: HUS Neurocenter, Neurologian yksikkö, Helsinki University Hospital Area

    وصف الملف: application/pdf

    العلاقة: AM, KK, MSK, KJ, JAKH and ML have nothing to disclose. DAS reports travel support from Boehringer Ingelheim, advisory board participation for AstraZeneca, DSMB participation for the SECRET trial, and being a member of the ESO Executive Committee. MRH reports grants from the Swiss Heart Foundation and Bangerter Foundation, travel support from Bayer, and DSMB or advisory board participation for Amgen, and being a member of the ESO Board of Directors and of the ESO Education Committee. EL reports academic grants from the Swedish Neurological Society, Elsa and Gustav Lindh's Foundation, P‐O Ahl's Foundation and Rune and Ulla Amlöv's Foundation. TT has served/serves on scientific advisory boards for Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Inventiva, Portola Pharm and PHRI; has/has had research contracts with Bayer, Boehringer Ingelheim and Bristol Myers Squibb. JP reports grants paid to his institution from the Academy of Finland, Hospital District of Helsinki and Uusimaa, and Finnish Foundation for Cardiovascular Research, consulting fees from Boehringer‐Ingelheim, Bayer and Herantis Pharma, payment for honoraria, lectures, presentations, speakers bureaus, manuscript writing or educational events from Boehringer Ingelheim, Bayer and Abbot, and stock ownership in Vital Signum. SM reports grants from Bayer paid to her institution, personal fees from Bayer paid to her institution, grants from Pfizer paid to her institution, personal fees from BMS/Pfizer paid to her institution, grants from Boehringer Ingelheim paid to her institution, personal fees from Boehringer Ingelheim paid to her institution, personal fees from Abbvie paid to her institution, personal fees from Portola/Alexion paid to her institution, grants from Daiichi Sankyo paid to her institution, and personal fees from Daiichi Sankyo paid to her institution outside the submitted work. MA reports honoraria for lectures from Bayer, AstraZeneca, Covidien and Medtronic, and honoraria for scientific advisory board participation from Amgen, Bayer, BMS, Daiichi Sankyo, Medtronic and Novartis. JMF reports fees and DSMB or advisory board participation for Boehringer Ingelheim and consulting fees from Bayer. JMC reports grants, paid to his institution from Boehringer Ingelheim and Bayer, and payments, paid to his institution for DSMB participation by Bayer. There were no other relationships or activities that could appear to have influenced the submitted work.; van de Munckhof , A , Krzywicka , K , Aguiar de Sousa , D , Sánchez van Kammen , M , Heldner , M R , Jood , K , Lindgren , E , Tatlisumak , T , Putaala , J , Kremer Hovinga , J A , Middeldorp , S , Levi , M , Arnold , M , Ferro , J M & Coutinho , J M 2022 , ' Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination ' , European Journal of Neurology , vol. 29 , no. 1 , pp. 339-344 . https://doi.org/10.1111/ene.15113Test; 85115943005; e26c3b8c-6beb-441c-820d-12e31e15be03; http://hdl.handle.net/10138/340039Test; 000702318000001

  3. 3

    المصدر: Frontiers in Cardiovascular Medicine
    Nilius, Henning; Mertins, Tamara; Boss, Robin; Knuchel, Matthias; Blozik, Eva; Kremer Hovinga, Johanna Anna; Eichinger, Sabine; Nagler, Michael (2021). Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study. Frontiers in cardiovascular medicine, 8(749342), p. 749342. Frontiers 10.3389/fcvm.2021.749342 <http://dx.doi.org/10.3389/fcvm.2021.749342Test>

    وصف الملف: application/pdf